Walleye Capital’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.9K Sell
2,600
-19,500
-88% -$605K ﹤0.01% 3700
2025
Q4
$618K Buy
22,100
+7,000
+46% +$210K ﹤0.01% 2818
2025
Q3
$453K Buy
+15,100
New +$426K ﹤0.01% 2698
2023
Q4
Sell
-800
Closed -$22.4K 4891
2023
Q3
$22.4K Buy
+800
New +$23.5K ﹤0.01% 4364
2019
Q3
Sell
-13,600
Closed -$307K 1859
2019
Q2
$307K Buy
13,600
+9,400
+224% +$258K 0.03% 721
2019
Q1
$153K Buy
+4,200
New +$139K 0.03% 880

Other funds holding ALKS

Walleye Capital's ALKS Position: Q1 2026 in Review

Walleye Capital reduced its Alkermes (ALKS) stake by 77% in Q1 2026, selling an estimated $514K and leaving 5,029 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #3404.

Walleye Capital first reported a position in ALKS in Q1 2019 and has held it in 10 quarters since. The position peaked at $2.57M in Q2 2022. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Walleye Capital held 5,029 shares of Alkermes worth $178K as of Q1 2026.
  • Walleye Capital sold 16,568 Alkermes shares in Q1 2026, an estimated $514K.
  • Alkermes made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3404 holding.
  • Walleye Capital first reported a position in Alkermes in Q1 2019 and has held it in 10 quarters since.
  • Walleye Capital's Alkermes position peaked at $2.57M in Q2 2022.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.